| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 669728 | Null | 0.0291420747327558 | 0.37754912 |
| NSC 672304 | Null | 0.0291420747327558 | 0.24449676 |
| NSC 685964 | Null | 0.0291420747327558 | 0.21706968 |
| NSC 688228 | Null | 0.0291420747327558 | 0.18554069 |
| NSC 697535 | Null | 0.0291420747327558 | 0.49416053 |
| NSC 718564 | Null | 0.0291420747327558 | -0.0042664932 |
| NSC 718630 | Null | 0.0291420747327558 | 0.41935169 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0291420747327558 | 0.15132558 |
| NSC 726442 | 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride | 0.0291420747327558 | 0.31648646 |
| NSC 727620 | 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride | 0.0291420747327558 | 0.20002384 |